Latest News

Tel Aviv hit by missile fired from Yemen,...

What we know about the suspect behind the...

30 people die in a crash between a...

How a teenager’s holiday romance led to prison...

AI cameras are giving DC’s air defense a...

New report warns of growing national security threat...

DAVID MARCUS: De facto President Trump’s handling of...

Trump nominates TV producer, creator of ‘The Apprentice,’...

Lawmakers react to stopgap funding and averting government...

Trump nominates pair to help lead DOJ, announces...

World
Politics
Investing
Business

Home Investing RAD 202 receives approval to start Phase 1 therapeutic trial

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024

December 20, 2024

5

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0 Facebook Twitter Pinterest Email

previous post

5 Best-performing Canadian Nickel Stocks of 2024

next post

Forum Comments on Share Price

You may also like

Stardust Power Acquires Site, Receives Key Permit And...

December 22, 2024

Tech 5: Bitcoin Drops Below US$100,000, Micron Guidance...

December 22, 2024

Brunswick Exploration Closes Upsized Non-Brokered Private Placement of...

December 21, 2024

Skyharbour Announces Closing of Private Placement for Gross...

December 21, 2024

Silver Price Forecast: Top Trends That Will Affect...

December 21, 2024

FALCO ANNOUNCES CLOSING OF BROKERED PRIVATE PLACEMENT

December 21, 2024

Top 5 Canadian Mining Stocks This Week: Omineca...

December 21, 2024

Opawica Announces the Closing of Non-Brokered Private Placement

December 21, 2024

Awalé Expands BBM Trend to Over 15km with...

December 20, 2024

Hempalta Corp. Announces Financial Results for Year Ended...

December 20, 2024

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Latest

Tel Aviv hit by missile fired from Yemen, Israel and Houthis say

December 22, 2024
What we know about the suspect behind the German Christmas market attack

December 22, 2024
30 people die in a crash between a passenger bus and a truck in Brazil

December 22, 2024
How a teenager’s holiday romance led to prison time in Dubai

December 22, 2024
AI cameras are giving DC’s air defense a major upgrade

December 22, 2024

Categories

Business (1,030)
Investing (2,165)
Politics (2,967)
World (2,899)

About us
Contact us
Privacy Policy
Terms & Conditions

Disclaimer: Trader Talk to You, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 Trader Talk to You | All Rights Reserved

World
Politics
Investing
Business